Genomic characterization of a mobile-element-associated resistance island in trimethoprim-sulfamethoxazole resistant Stenotrophomonas maltophilia isolates sharing the same PFGE genotype


Creative Commons License

Altan G., Rakıcı E., Dündar D., Özgümüş O. B.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, cilt.16, sa.1926102, ss.1-14, 2026 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 16 Sayı: 1926102
  • Basım Tarihi: 2026
  • Doi Numarası: 10.3389/fcimb.2026.1926102
  • Dergi Adı: FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
  • Derginin Tarandığı İndeksler: Natural Science Collection (ProQuest), Biological Science Database (ProQuest), Health Research Premium Collection (ProQuest), Scopus, Science Citation Index Expanded (SCI-EXPANDED), BIOSIS, EMBASE, MEDLINE, Directory of Open Access Journals, Zoological Record
  • Sayfa Sayıları: ss.1-14
  • Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
  • Recep Tayyip Erdoğan Üniversitesi Adresli: Evet

Özet

Background: Stenotrophomonas maltophilia is an opportunistic nosocomial

pathogen with intrinsic multidrug resistance and limited therapeutic options.

This study integrated phenotypic susceptibility testing, targeted molecular

screening, PFGE and short-read whole-genome sequencing (WGS) to

characterize resistance determinants and their local genomic context in

clinical-culture isolates.

Methods: Thirty-four non-duplicate clinical-culture isolates were analyzed.

Susceptibility to trimethoprim-sulfamethoxazole (TMP-SMX), levofloxacin and

minocycline was determined by disk diffusion. Minocycline testing was repeated

with acceptable quality control, and the repeat-run zone records were reassessed

using current CLSI breakpoints. A predefined, hypothesis-driven PCR panel was

used to screen selected resistance-, efflux- and biofilm-associated targets, and

gyrA, gyrB, parC and parE were sequenced. Genetic relatedness was assessed by

XbaI-PFGE. Three selected isolates (S05, S08 and S25) underwent WGS as a

targeted genomic-context analysis rather than a whole-collection populationgenomic

study.

Results: Resistance rates were 5.9% for TMP-SMX, 8.8% for levofloxacin and 11.8%

for minocycline after reassessment using current CLSI minocycline breakpoints.

Smqnr- and sul1-target PCR positivity was observed in 61.8% and 8.8% of isolates,

respectively. A dfrA27-target PCR amplicon was observed in 82.4% of isolates but

was not associated with TMP-SMX resistance and was not confirmed in the three

sequenced genomes. No QRDR hotspot mutations were identified. The two TMPSMX-

resistant isolates, S05 and S08, shared the same PFGE genotype. Short-read

WGS identified an identical 19,361-bp mobile-element-associated resistance

region in these isolates, containing a putative Sul-family/folP-like

dihydropteroate synthase (DHPS) annotation, two assembly-predicted hits each

of blaOXA-2 and ant(3’’), multiple insertion sequences and a mercury-resistance

module; the region was absent from S25.

Frontiers